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Abstract
Background: Postnatal muscle growth is largely depending on the number and size of muscle fibers. The
number of myofibers and to a large extent their metabolic and contractile properties, which also influence
their size, are determined prenatally during the process of myogenesis. Hence identification of genes and
their networks governing prenatal development of skeletal muscles will provide insight into the control of
muscle growth and facilitate finding the source of its variation. So far most of the genes involved in
myogenesis were identified by in vitro studies using gene targeting and transgenesis. Profiling of
transcriptome changes during the myogenesis in vivo promises to obtain a more complete picture. In order
to address this, we performed transcriptome profiling of prenatal skeletal muscle using differential display
RT-PCR as on open system with the potential to detect novel transcripts. Seven key stages of myogenesis
(days 14, 21, 35, 49, 63, 77 and 91 post conception) were studied in two breeds, Pietrain and Duroc, differing
markedly in muscularity and muscle structure.
Results:  Eighty prominent cDNA fragments were sequenced, 43 showing stage-associated and 37
showing breed-associated differences in the expression, respectively. Out of the resulting 85 unique
expressed sequence tags, EST, 52 could be assigned to known genes. The most frequent functional
categories represented genes encoding myofibrillar proteins (8), genes involved in cell adhesion, cell-cell
signaling and extracellular matrix synthesis/remodeling (8), genes regulating gene expression (8), and
metabolism genes (8). Some of the EST that showed no identity to any known transcripts in the databases
are located in introns of known genes and most likely represent novel exons (e.g. HMGA2). Expression of
thirteen transcripts along with five reference genes was further analyzed by means of real-time quantitative
PCR. Nine of the target transcripts showed higher than twofold differences in the expression between the
two breeds (GATA3, HMGA2, NRAP, SMC6L1, SPP1, RAB6IP2, TJP1 and two EST).
Conclusion: The present study revealed several genes and novel transcripts not previously associated
with myogenesis and expands our knowledge of genetic factors operating during myogenesis. Genes that
exhibited differences between the divergent breeds represent candidate genes for muscle growth and
structure.
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Background
Prenatal development of skeletal muscle, myogenesis, is
an ideal model to study cell determination and differenti-
ation. Accordingly myogenesis has become an extensively
studied process in model animals [1]. Because muscle
regeneration resembles myogenesis the study of myogen-
esis provides basic knowledge for the development of
therapies to treat human muscle disease [2]. In farm ani-
mal biology the interest in myogenesis is driven mainly by
the perception that muscle growth potential is associated
with muscle fiber number and muscle structure, i.e. with
characteristics that are determined prenatally during myo-
genesis [3]. The relationship between muscle mass and
muscle fiber number as well as muscle structure is well
illustrated by the observation that domestic pigs selected
for muscularity exhibit a higher number of myofibers and
an increased proportion of fast twitch glycolytic fibers
(the myofiber type with the largest cross sectional area in
the pig) compared to their wild ancestor or unimproved
breeds [3,4]. Morphological studies of myogenesis in the
pig are scarce. Development of somites takes place
approximately between day 14 and 22 of gestation.
Around day 35 of gestation the formation of primary
myotubes starts and proceeds until around day 60. The
secondary population of myotubes appears around day
50 (45–54) on the surface of the primary myotubes,
which they use as a scaffold. The number of secondary
myotubes increases several fold until day 75. Afterwards
the number increases only slightly. Around days 85–90
the fiber formation ceases and the total number of fibers
is established. The process of maturation of the myotubes
into myofibers is finished in the early postnatal period
[5,6]. In the pig, primary myotubes are a minor constitu-
ent of muscle fibers. In adult muscle, the ratio of primary
to secondary myotubes is about 1:20. However, both pop-
ulations of myotubes significantly influence fiber number
and consequently muscle size. The importance of both
primary and secondary myotubes for muscle growth is
underscored by the lower number of primary fibers and a
lower secondary to primary fiber ratio in small compared
to large pig breeds [7,8].
Knowledge of genetic and epigenetic factors that govern
formation of both generations of myotubes will facilitate
the understanding of the control of muscle growth and
structure. Application of transcriptome profiling technol-
ogies largely enhances our knowledge of these factors and
facilitates uncovering the myogenic gene networks. So far
transcriptome profiling of myogenesis in livestock was
performed using macroarrays [9,10] or application spe-
cific microarrays [11-13]. However, only a limited
number of specified genes could be analyzed using these
methodologies.
In the present study we employed a complementary meth-
odology, differential display RT-PCR, as an open system
that facilitates the identification and the analysis of yet
unknown transcripts. We analyzed myogenesis in two
breeds differing in muscularity and muscle structure: the
Pietrain breed with higher muscularity, higher number of
muscle fibers and a higher proportion of glycolytic muscle
fibers and the Duroc breed with lower muscularity and
higher proportion of slow twitch muscle fibers [4,14]. The
aim of this study was the identification of genes and path-
ways whose expression profile during development of
porcine skeletal muscle implicates their involvement in
myogenesis. In addition genes that were found to be dif-
ferentially expressed between Pietrain and Duroc repre-
sent candidate genes with potential impact on muscle
growth and structure.
Results
Differential display RT-PCR profiling of the transcriptome 
during porcine myogenesis
Comparison of a total of 88 differential display profiles
between stages and between breeds revealed 458 cDNA
fragments differing in their presence and/or in their inten-
sity. Out of these, 310 cDNA fragments showed similar
stage-associated differences in the expression in both
breeds and 148 fragments were differentially displayed
between breeds. Though the essentially binary expression
patterns and the inefficient and tedious cloning of the dif-
ferentially displayed cDNA fragments hamper a global
view of the expression changes and a comprehensive path-
way analysis, we attempted to assign cDNA fragments to
groups based on their expression patterns and to relate
these to functional pathways. Stage-associated cDNA frag-
ments were classified into five groups of patterns ('period'
groups) according to their distribution and/or changes in
the intensity between the stages. The first group is related
to early development (period 1; either present only or
apparently upregulated at 14 dpc and 21 dpc). The second
and third groups are related to the first wave (period 2;
either present only or apparently upregulated at 14 – 49
dpc) and the second wave (period 3; either present only or
apparently upregulated at 49 – 91 dpc) of myogenesis
respectively. The fourth group included fragments present
at both first and the second wave of myogenesis (period 4;
either present only or apparently upregulated at 21 – 91
dpc). The fifth group contained fragments present at all 7
stages that showed either steady up- or downregulation
(period 5). In order to perform a similar grouping of the
breed-associated cDNA fragments according to their tem-
poral expression across stages one such fragment was
called present at a particular stage if it was present in one
of the two breeds (under the assumption that the absence
in the other breed was due to lower expression level or a
SNP in the priming site).BMC Developmental Biology 2007, 7:109 http://www.biomedcentral.com/1471-213X/7/109
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Reamplification, cloning and sequencing was successfully
performed for 43 breed- and 37 stage-associated cDNA
fragments (Tables 1 and 2). Two breed-associated and
four stage-associated differential display bands were
found to represent multiple (2–3) different cDNA frag-
ments of nearly identical length. The sequences of the
cDNA fragments bR21D1 and bR10D1 were embedded in
the larger EST bS19C1 and qR10D1, respectively, thus in
total 85 unique EST (44 breed- and 41 stage- associated)
were generated [GenBank:DQ631863, EH792585–
EH792670]. Homology search revealed that 45 EST repre-
sented known genes, 20 EST showed similarity to other
anonymous EST/cDNA in the database, 3 EST showed
similarity to genomic clones, 2 EST were homologous to
mitochondrial DNA (genes) and 17 EST did not match
any database entries. The MALAT1 gene was represented
by two different EST representing cDNA fragments with
similar expression patterns (qR24B1 and bS22B1#2;
period 4). Taking advantage of the high homology
between pig and human sequences, we could assign 8 EST
similar to anonymous EST/cDNA and 2 EST with genome
hits to gene loci by BLAST search of the human genome.
In total 55 EST were assigned to 52 genes.
The most frequent functional categories represented genes
encoding myofibrillar genes (8 genes: MYH3,  MYH1,
TNNI2,  MYPN,  MYH2,  TTN,  NRAP,  TPM1), genes
involved in cell adhesion, cell-cell signaling and extracel-
lular matrix synthesis/remodeling (8 genes: SDC3,
LAMB1,  SSPN,  IGSF1,  SPARCL1,  SPP1,  TIMP2,  TJP1),
genes regulating gene expression (8 genes: BICC1, GATA3,
HMGA2, HMGN1, JMJD2A, RAB6IP2, SETBP1, SMAD7)
and metabolism genes (8 genes: ARNIP, GLUD1,LTB4DH,
LXN, ND2, ND4L, NDUFA10, RPL37). The myofibrillar
genes and genes involved in cell adhesion, cell-cell signal-
ing and extracellular matrix synthesis/remodeling were
almost exclusively represented in the period 4 group (i.e.
they were expressed from 21–35 dpc onward).
Another functional group enriched in the period 4 group
were cytoskeletal genes related to assembly of actin fila-
ments (3 genes: ACTC,  CFL2,  SYNE2). The remaining
functional groups showed no obvious enrichment in a
specific period group.
Regarding the breed-associated cDNA fragments, 28 were
present/more intense in Pietrain and 15 were present/
more intense in Duroc (Table 2). Genes related to cell
adhesion, cell-cell signaling and extracellular matrix syn-
thesis/remodeling and those from period group 4 tended
to be enriched among the Pietrain differentials and genes
related to metabolism and those from period group 2
tended to be enriched among the Duroc differentials.
Analysis of expression profiles of reference genes
The use of reference genes for normalization of real-time
quantitative PCR (qPCR) data requires identification of
genes which show constant expression under given exper-
imental conditions. We analyzed expression profile of five
potential reference genes, three (ACTB, RPL32, POLR2A)
widely used and described [15,16], and two (AGPAT1
involved in phospholipid metabolism and CANX
involved in protein folding) showing stable expression in
microarray studies comparing expression signatures of
different tissues and/or developmental stages [17,18]. Not
unexpectedly, considering the major changes in the cell
type composition and the structure of the tissue samples,
none of the five genes turned out to be expressed at con-
stant levels across the seven prenatal stages (Figure 1).
Expression of ACTB,  POLR2A,  CANX  showed steady
downregulation from 14 dpc onwards, whereas expres-
sion of RPL32 and AGPAT1 peaked at 21 dpc and was
downregulated thereafter. All three reference genes ana-
lyzed in adult muscle (RPL32,  AGPAT1,  CANX) were
downregulated compared to prenatal stages. Therefore we
calculated a normalization factor based on the five refer-
ence genes (three for adult muscle) within stages, thus
accounting for technical variation between breeds but not
between stages.
Validation of stage- and/or breed-associated differential 
expression of individual genes
In previous expression studies performed in our labora-
tory using differential display RT-PCR the incidence of
false positives was low with about 23% [19], however, in
other studies employing differential display RT-PCR the
rate of false positives reached as much as ~80% in some
cases [20]. Therefore expression patterns of thirteen genes
showing stage- and/or breed-associated differential
expression were validated by qPCR. We focused the vali-
dation mainly on the breed-associated genes because they
represent primary candidates for finding the source of var-
iation in muscularity and meat quality in pigs. All genes
were selected so that (1) different expression patterns and/
or (2) different functional pathways were represented.
Three stage-associated genes, namely NME,  IGSF1  and
HMGA, were validated.
Expression of NME1 showed steady downregulation from
21 dpc onward (Figure 1F).
Expression of IGSF1 was low/absent at 14 dpc, increased
dramatically until 63 dpc, stayed at similar level until 91
dpc and was downregulated in adult muscle nearly to the
starting level at 14 dpc (Figure 1G). At all stages the differ-
ences in expression of NME1 and IGSF1 between Pietrain
and Duroc were lower than twofold.BMC Developmental Biology 2007, 7:109 http://www.biomedcentral.com/1471-213X/7/109
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Table 1: Summary of EST showing stage-associated differential expression during porcine myogenesis
EST/Clone Accession 
number
Identity1 Species Accession 
number
Similarity Function Period 
group
Expression 
pattern2
bS9C3 EH792591 Syndecan 3 (SDC3) Bovine XM_870523 106/127 (83%) cell adhesion, 
ECM
1 1-1-0-0-0-0-0
bS17A2 EH792585 Ribosomal protein L37a 
(RPL37A)
Canine AY197363.1 146/172 (84%) metabolism 1 0-1 > 1-1-1-1-1
bS24A4 EH792589 Glutamate 
dehydrogenase 1 
(GLUD1)
Human X67491.1 157/173 (90%) metabolism 1 1-1-0-0-0-0-0
bS9B1 EH792590 EST Porcine BE235673 237/283 (83%) other, unknown 1 1-0-0-0-0-0-0
bS17C2 EH792586 Unknown other, unknown 1 0-1-0-0-0-0-0
bS17D3 EH792587 EST Bovine CB169367 146/169 (86%) other, unknown 1 0-1-0-0-0-0-0
bS18D2 EH792588 Unknown other, unknown 1 1-1-0-0-0-0-0
bS8D1 EH792602 ATG3 autophagy related 
3 homolog (S. cerevisiae) 
(ATG3)
Human NM_022488 132/146 (90%) cell death, 
autophagy
2 0-1-1-0-0-0-0
bS9C4 EH792603 EST, [Insulin-like growth 
factor binding protein-
like 1 (IGFBPL1)]
Porcine CK465405 202/205 (98%) cell proliferation 2 0-1 > 1-0-0-0-0
bS24D3#2 EH792596 Non-metastatic cells 1, 
protein (NM23A) 
expressed in (NME1)
Human NM_198175.
1
333/387 (86%) cell proliferation 2 1-1-1-1 > 1-1-1
bS2B3#1 EH792598 Mitochondrion, [NADH 
dehydrogenase subunit 
4L (ND4L)]
Porcine AY334492 146/146 (100%) metabolism 2 0-1-1-1-0-0-0
bS2B3#2 EH792599 Signal sequence receptor, 
gamma (SSR3)
Human NM_007107 82/90 (91%) other, unknown 2 0-1-1-1-0-0-0
bS2B4 EH792600 5'-nucleotidase domain 
containing 2 (NT5DC2)
Human BC014550.1 120/130 (92%) other, unknown 2 0-1-1-1-0-0-0
bS2B1 EH792597 Unknown other, unknown 2 0-1-1-1-0-0-0
bS24D3#1 EH792595 EST Porcine BG835728 122/123 (99%) other, unknown 2 1-1-1-1 > 1-1-1
bS3D7 EH792601 High mobility group AT-
hook 2 (HMGA2)
Human AF326972 198/235 (84%) regulation of 
transcription
2 0-1 > 1 > 1-1-1-1
bS9C7 EH792614 Homo sapiens genomic 
DNA, chromosome 11q, 
clone:CTD-2011F17, 
[UV radiation resistance 
associated gene 
(UVRAG)]
Human AP002340 58/67 (86%) cell death, 
autophagy
3 0-0-0-0-1-1-1
qS24D2 EH792616 Tropomyosin 1, alpha 
(TPM1)
Porcine X66274.1 373/376 (99%) myofibrill 
assembly
3 0-1-1 < 1-1-1-1
bS15C2 EH792628 TIMP metallopeptidase 
inhibitor 2 (TIMP2)
Porcine AF156030 146/178 (82%) cell adhesion, 
ECM
4 0-0-1-1-1-1-1
bS19C1 EH792632 Immunoglobulin 
superfamily, member 1 
(IGSF1)
Canine XM_538173.1 351/391 (89%) cell adhesion, 
ECM
4 0-1 < 1-1-1-1-1
bS3D8 EH792642 Actin, alpha, cardiac 
muscle (ACTC)
Human NM_005159.
3
172/184 (93%) cell structure 4 0-1-1-1-1-1-1
bS14D2 EH792627 Cofilin 2, muscle (CFL2) Human NM_138638.
1
128/139 (92%) cell structure 4 0-0-1-1-1-1-1
bS20A3 EH792635 Myosin, heavy 
polypeptide 1, skeletal 
muscle, adult (MYH1)
Porcine AB025262 237/245 (96%) myofibrill 
assembly
4 0-0-1-1-1-1-1
bS1B3 EH792633 Troponin I type 2, 
skeletal, fast (TNNI2)
Porcine NM_0010323
59
50/51 (98%) myofibrill 
assembly
4 0-0-1-1-1-1-1
bS18B1 EH792631 Myopalladin (MYPN) Canine XM_546131.1 96/100 (96%) myofibrill 
assembly
4 0-0-1-1-1-1-1
bS14C4 EH792626 Myosin, heavy 
polypeptide 3, skeletal 
muscle, embryonic 
(MYH3)
Bovine AB090155.1 292/312 (93%) myofibrill 
assembly
4 0-1 < 1-1-1-1-1
bS15C4 EH792629 Myosin, heavy 
polypeptide 2 (MYH2)
Porcine NM_214136.
1
249/270 (92%) myofibrill 
assembly
4 0-0-1-1-1 > 1 > 1BMC Developmental Biology 2007, 7:109 http://www.biomedcentral.com/1471-213X/7/109
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Expression of HMGA2 was barely detectable at 14 dpc,
reached maximum at 21–35 dpc, decreased substantially
at 49 dpc, stayed at similar low level until 91 dpc and was
essentially shut down in adult muscle (Figure 1H). The
sensitive qPCR revealed a ~2.5-fold higher expression of
HMGA2 in Pietrain at 49 dpc, not detected by differential
display RT-PCR.
The expression patterns of ten breed-associated genes and
EST were validated.
Expression of GATA3 as revealed by qPCR was highest at
14 dpc (Figure 2A). At 21 dpc the expression decreased,
with more pronounced downregulation in Duroc
embryos. In agreement with the results of differential dis-
play RT-PCR the expression lasted in Duroc embryos/
fetuses until 49 dpc whereas in Pietrain embryos/fetuses
the expression ceased already at 35 dpc.
The EST bR24D1, that was found in Duroc from 35 dpc
onward only, was homologous to intron 6 of the SPP1
gene. Since we used total RNA for differential display RT-
PCR we reasoned that this EST was derived from hetero-
nuclear RNA (hnRNA) and thereby reflected higher active
transcription of SPP1 in Duroc. QPCR using exon specific
primers showed that expression of SPP1 peaked at 35 and
77 dpc, i.e. at the time-points of the two myogenic waves,
and confirmed consistently higher expression of SPP1 in
Duroc at all seven prenatal stages (Figure 2B). The differ-
ence was highest at 14 dpc (~20-fold), afterwards gradu-
ally decreased until 49 dpc (~3.6-fold to ~1.3-fold) and
remained at similar magnitude until 91 dpc. In adult mus-
cle no differences were found.
The SMC6L1 gene was expressed throughout myogenesis
as shown consistently by both, differential display RT-
PCR and qPCR (Figure 2C). QPCR revealed more than
twofold upregulation of SMC6L1 at 35 and 49 dpc in Pie-
train in agreement with differential display RT-PCR and
additionally at 91 dpc, but no difference was found at 14
dpc.
For the remaining breed-associated EST/genes no clear
relationship between profiles obtained using differential
display RT-PCR and qPCR respectively could be estab-
lished.
The expression profile of RAB6IP2 showed two peaks, one
higher at 21–35 dpc and another at 63 dpc, i.e. at the
onset of the two waves of myofiber formation. Expression
qS4D7 EH792660 Titin (TTN) Human NM_003319.
2
318/353 (90%) myofibrill 
assembly
4 0-0-1 < 1 < 1-1-1
bS4B3 EH792643 Unknown other, unknown 4 0-0-1-1-1-1-1
bS22B1#1 EH792636 EST [Chromosome 6 
open reading frame 89 
(C6orf89)]
Porcine BP142021 147/151 (97%) other, unknown 4 0-0-1-1-1-1-1
bS22B1#2 EH792637 Metastasis associated 
lung adenocarcinoma 
transcript 1 (MALAT1)
Human NR_002819 204/240 (85%) other, unknown 4 0-0-1-1-1-1-1
bS26B3 EH792640 EST Porcine BX918881 52/55 (94%) other, unknown 4 0-0-1-1-1-1-1
bS22C2#1 EH792638 EST Porcine BQ599825 98/106 (92%) other, unknown 4 0-1 < 1-1-1-1-1
bS22C2#2 EH792639 EST Porcine CB473363 90/105 (85%) other, unknown 4 0-1 < 1-1-1-1-1
bS12D1 EH792624 EST Porcine CV866720 191/204 (93%) other, unknown 4 0-1 < 1-1-1-1-1
bS17B3 EH792630 High-mobility group 
nucleosome binding 
domain 1 (HMGN1)
Canine BX641076 292/308 (94%) regulation of 
transcription
4 0-1 < 1 < 1 < 1 < 
1 < 1
bS14C2 EH792625 DEP domain containing 5 
(DEPDC5)
Human BC057797.1 189/206 (91%) signal 
transduction
4 0-0-1-1-1-1-1
bS20A2 EH792634 ATP synthase, H+ 
transporting, 
mitochondrial F1 
complex, gamma 
polypeptide 1 (ATP5C1)
Bovine XM_873667 177/195 (90%) transport 4 0-0-1-1-1-1-1
bS2D1 EH792641 Hemoglobin, beta (HBB) Porcine X86791 191/197 (96%) transport 4 0-1 < 1-1-1-1-1
qS20A1 EH792670 Mitochondrion, [NADH-
ubiquinone 
oxidoreductase chain2 
(ND2)]
Rabbit AJ012536 237/240 (98%) metabolism 5 1-1 > 1 > 1 > 1 > 
1 > 1
qS15D1 EH792669 Ataxin 10 (ATXN10) Porcine AY550076 169/193 (87%) other, unknown 5 1 > 1 > 1 > 1 > 1 
> 1-1
1In square brackets the identity derived by cross-species megaBLAST search of the human genome sequence is indicated
2 Binary coding of the differential display RT-PCR pattern (1-present, 0-absent)
Table 1: Summary of EST showing stage-associated differential expression during porcine myogenesis (Continued)BMC Developmental Biology 2007, 7:109 http://www.biomedcentral.com/1471-213X/7/109
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Table 2: Summary of EST showing differences in expression during myogenesis between Pietrain and Duroc breeds of pigs
EST/Clone Accession 
number
Identity1 Species Accession 
number
Similarity Function Period 
group
Expression 
pattern2
qR15A1#2 EH792605 Androgen receptor N-
terminal-interacting protein 
(ARNIP)
Human AF247041 254/267 (95%) metabolism 2 D-1-D-0-0-0-0
qR15A1#3 EH792606 NADP dependent leukotriene 
b4 12-hydroxydehydrogenase 
(LTB4DH)
Porcine NM_214385 235/243 (96%) metabolism 2 D-1-D-0-0-0-0
qR8A1 EH792608 Unknown other, 
unknown
2 D-D-D-0-0-0-0
bR9C1 EH792594 Unknown other, 
unknown
2 D-D-D-D-0-0-0
qR24C1 EH792607 Pan troglodytes chromosome 
22 clone:RP43-009O02
Chimp BS000013 92/112 (82%) other, 
unknown
2 D-1-D-0-0-0-0
bR4D1 EH792593 Unknown other, 
unknown
2 0-1-D-0-0-0-0
bR13B4 EH792592 GATA binding protein 3 
(GATA3)
Porcine DQ450901 189/193 (97%) regulation of 
transcription
2 1-1-D-0-0-0-0
qR15A1#1 EH792604 DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 17 (DDX17)
Human NM_030881 230/259 (88%) RNA/DNA 
metabolism
2 D-1-D-0-0-0-0
bR21D1 EH792610 Immunoglobulin superfamily, 
member 1 (IGSF1)
Canine XM_538173 199/212 (93%) cell adhesion, 
ECM
3 0-0-0-0-0-P-P
bR2B1 EH792611 Unknown other, 
unknown
3 0-0-0-1-1-P-0
bR8B2 EH792613 Unknown other, 
unknown
3 0-0-0-0-0-P-P
bR18D1 EH792609 Unknown other, 
unknown
3 0-0-0-0-D-1-1
bR7D1 EH792612 RAB6 interacting protein 2 
(RAB6IP2)
Human NM_178037 268/287 (93%) regulation of 
transcription
3 0-0-0-0-D-1-1
qR7B2 EH792615 Rap guanine nucleotide 
exchange factor (GEF) 5 
(RAPGEF5)
Human BC039203 62/73 (84%) signal 
transduction
3 0-0-0-P-P-P-P
qR3B1 EH792655 EST [Laminin, beta 1 (LAMB1)] Porcine BE030491 171/174 (98%) cell adhesion, 
ECM
4 0-P-P-P-1-1-1
qR4D2 EH792658 EST [Sarcospan (SSPN)] Porcine BX924101 469/475 (98%) cell adhesion, 
ECM
4 0-P-P-1-1-1-1
qR19D1 EH792650 SPARC-like 1 (SPARCL1) Human NM_004684 198/236 (83%) cell adhesion, 
ECM
4 0-0-P-P-P-P-P
qR22D1 EH792652 Tight junction protein 1 (TJP1) Human NM_003257 447/486 (91%) cell adhesion, 
ECM
4 0-0-P-P-P-0-0
bR24D1 EH792623 Secreted phosphoprotein 1 
(SPP1)
Porcine AJ237667 125/126 (99%) cell adhesion, 
ECM
4 0-0-D-D-D-D-D
qR14A1#2 EH792645 Spectrin repeat containing, 
nuclear envelope 2 (SYNE2)
Human BC042134 88/100 (88%) cell structure 4 0-0-1-D-D-D-D
qR1A1 EH792651 NADH dehydrogenase 
(ubiquinone) 1 alpha 
subcomplex 10 (NDUFA10)
Bovine NM_176655 84/90 (93%) metabolism 4 0-0-1-1-1-1-D
qR14A1#1 EH792644 Latexin (LXN) Human BC008438 133/151 (88%) metabolism 4 0-0-1-D-D-D-D
bR13B8 EH792618 Nebulin-related anchoring 
protein (NRAP)
Porcine DQ157553 199/200 (99%) myofibrill 
assembly
4 0-P-P-P-P-P-0
bR24A1 EH792621 Unknown other, 
unknown
4 0-P-P-P-P-P-P
qR4B1 EH792656 Unknown other, 
unknown
4 0-P-P-P-1-1-1
qR24B1 EH792653 Metastasis associated lung 
adenocarcinoma transcript 1 
(MALAT1)
Human NR_002819 72/79 (91%) other, 
unknown
4 0-0-P-P-1-1-1
qR25B3 EH792654 Unknown other, 
unknown
4 0-0-P-P-P-P-P
qR5C1 EH792659 EST Porcine CJ014638 195/228 (85%) other, 
unknown
4 0-0-P-P-1-1-P
qR15C1 EH792647 Unknown other, 
unknown
4 0-D-P-P-P-0-0BMC Developmental Biology 2007, 7:109 http://www.biomedcentral.com/1471-213X/7/109
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qR19C1 EH792649 Unknown other, 
unknown
4 0-0-P-P-1-1-1
qR4D1 EH792657 Unknown other, 
unknown
4 0-P-P-P-1-1-1
bR15D1 EH792619 EST Porcine AJ956602 45/48 (93%) other, 
unknown
4 0-0-P-P-P-P-P
bR22D2 EH792620 EST Bovine AW344601 49/52 (94%) other, 
unknown
4 0-0-P-P-1-1-1
bR13B10 EH792617 EST [SMAD family member 7 
(SMAD7)]
Bovine DV922547 61/67 (91%) regulation of 
transcription
4 0-P-P-0-P-P-P
bR24C2 EH792622 EST [SET binding protein 1 
(SETBP1)]
Porcine BP172194 369/373 (98%) regulation of 
transcription
4 0-P-P-P-P-P-P
qR14C2 EH792646 Heterogeneous nuclear 
ribonucleoprotein D (HNRPD)
Murine AK077409 265/279 (94%) RNA/DNA 
metabolism
4 0-0-P-P-P-P-P
qR17B1 EH792648 Homo sapiens 12 BAC RP1
1-729I10 [ABCC9]
Human AC008250 75/87 (86%) transport 4 0-0-D-D-D-D-D
bR22B1 EH792663 Platelet-derived growth factor 
receptor, alpha polypeptide 
(PDGFRA)
Human NM_006206 252/287 (87%) cell 
proliferation
5 D-D-D-D-D-D-D
qR7B1 EH792668 SMC6 structural maintenance 
of chromosomes 6-like 1 
(SMC6L1)
Canine XM_532882 169/176 (96%) other, 
unknown
5 D-1-P-P-1-1-1
bR26B1 EH792664 Unknown other, 
unknown
5 P-P-P-P-1-P-1
qR10D1 EH792666 cDNA FLJ26539 fis [Bicaudal C 
homolog 1 (BICC1)]
Human AK130049 65/71 (91%) regulation of 
transcription
5 P-P-P-P-P-P-P
bR10D1 DQ631863 cDNA FLJ26539 fis [Bicaudal C 
homolog 1 (BICC1)]
Human AK130049 65/71 (91%) regulation of 
transcription
5 D-D-D-D-D-D-D
bR12D1 EH792661 EST Porcine AJ955354 51/51 (100%) other, 
unknown
5 P-P-P-P-P-P-P
qR20D1 EH792667 EST Porcine DV230345 71/71 (100%) other, 
unknown
5 P-P-P-P-P-P-P
bR2B2 EH792665 Jumonji domain containing 2A 
(JMJD2A)
Canine XM_539647 278/305 (91%) regulation of 
transcription
5 P-1-1-1-1-1-1
bR13A3 EH792662 Poly(A) polymerase gamma 
(PAPOLG)
Bovine XM_607511 217/229 (94%) RNA/DNA 
metabolism
5 D-D-D-D-D-D-D
1In square brackets the identity derived by cross-species megaBLAST search of the human genome sequence is indicated
2Binary coding of the differential display RT-PCR pattern (1-present in both breeds, 0-absent in both breeds, P-Present/More intense in Pietrain, D- 
Present/More intense in Duroc)
Table 2: Summary of EST showing differences in expression during myogenesis between Pietrain and Duroc breeds of pigs (Continued)
of  RAB6IP2  was consistently upregulated (~1.5 to ~3-
fold) throughout myogenesis in Pietrain compared to
Duroc with the most pronounced differences at 35–49
dpc (~2.5 to ~3-fold; Figure 2D).
The expression pattern of the EST bR22B1, homologous
to PDGFRA, obtained by differential display RT-PCR sug-
gested upregulation of PDGFRA in Duroc compared to
Pietrain embryos/fetuses. Indeed such upregulation was
found by qPCR at all stages but 35 and 49 dpc when the
situation was reversed (Figure 2E). The 1.2–1.4-fold
upregulation of PDGFRA detected by qPCR in Duroc cor-
related poorly with the results of differential display RT-
PCR. However, qPCR revealed a striking difference in the
expression pattern between Pietrain and Duroc. In Pie-
train the expression of PDGFRA gene showed a peak at 35
dpc whereas in Duroc two peaks existed, one at 21 dpc
and another at 63 dpc.
For TJP1 both, differential display RT-PCR and qPCR indi-
cated upregulation (≥2-fold) at 35 and 49 dpc in Pietrain
compared to Duroc (Figure 2F). No difference at 63 dpc
could be shown by qPCR. The expression of TJP1  was
highest at 14 dpc and in Duroc continuously decreased
until 49 dpc. In Pietrain a small peak at 35 dpc was
observed. From 63 dpc onward the expression stayed at a
similar level until 91 dpc in both breeds.
The expression profile of LXN as revealed by qPCR (Figure
2G) was similar to the expression profiles of RPL32 and
AGPAT1 (Figure 1C and 1E). The differences in the expres-
sion of LXN between breeds were less than twofold, but
especially in the early stages 21–49 dpc the expression was
consistently higher in Pietrain.
The expression of NRAP, as revealed by qPCR, was barely
detectable at 14 dpc and continuously increased in the
developing muscle until adult age (Figure 2H). At 35 dpc
the expression of NRAP was ~2-fold higher in Pietrain
compared to Duroc fetuses.BMC Developmental Biology 2007, 7:109 http://www.biomedcentral.com/1471-213X/7/109
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Expression of reference genes (A-E) and genes showing stage-associated differential display RT-PCR patterns (F-H) obtained by  qPCR Figure 1
Expression of reference genes (A-E) and genes showing stage-associated differential display RT-PCR patterns 
(F-H) obtained by qPCR. Histograms show normalized relative gene expression in Pietrain and Duroc embryos/Musculus 
longissimus dorsi at seven prenatal stages and in the adults (primary y-axis). For some genes data on expression in adults is miss-
ing. Open boxes and diamonds show absolute values of the Pietrain vs. Duroc expression ratios at each stage (log2(Pi/Du)). 
Open diamonds indicate higher expression in Duroc compared to Pietrain individuals and open boxes indicate the reverse sit-
uation (secondary y-axis).
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Expression of ten genes showing breed-associated differences in differential display RT-PCR patterns obtained by qPCR Figure 2
Expression of ten genes showing breed-associated differences in differential display RT-PCR patterns obtained 
by qPCR. Histograms show normalized relative gene expression in Pietrain and Duroc embryos/Musculus longissimus dorsi at 
seven prenatal stages and in the adults (primary y-axis). For some genes data on expression in adults is missing. Open boxes 
and diamonds show absolute values of the Pietrain vs. Duroc expression ratios at each stage (log2(Pi/Du)). Open diamonds 
indicate higher expression in Duroc compared to Pietrain individuals and open boxes indicate the reverse situation (secondary 
y-axis).
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The expression profile of the EST qR15C1 obtained using
qPCR resembled those of the HMGA2 gene (Figure 2I). A
peak was observed at 21–35 dpc and from day 49 dpc
onward the expression was maintained at low level; in
Pietrain about 2–4-fold higher compared to Duroc. In
adult muscle the expression was essentially switched off.
The temporal expression profile of the EST qR15C1 indi-
cated that the transcript might be involved in early devel-
opment. Unfortunately, the sequence of qR15C1 was very
short and showed no similarity with transcripts of known
genes. We took advantage of the ongoing sequencing of
the porcine genome and retrieved a trace sequence [NCBI
Trace Archiv:Ti 784825315] overlapping the EST. Using
this trace we were able to map the EST qR15C1 to intron
4 of the human kinesin family member 26B (KIF26B)
gene (Hsa1q44, 82% identity over 93 bp at 243749890
bp). Thus qR15C1 may represent a so far undetected exon
of KIF26B.
Sequencing of the two comigrating cDNA fragments
bR10D1 and qR10D1 revealed that they represent the
same transcript differing only in a 3 bp insertion/deletion
and that the differences between breeds obtained using
differential display RT-PCR were based on different fre-
quencies of the insertion/deletion in Duroc and Pietrain.
Nevertheless qPCR revealed that besides allelic variation
the transcript represented by the EST bR10D1/qR10D1
differed also in its abundance between the two breeds
(Figure 2J). In the early Duroc embryos at 14 dpc the
expression was about 4-fold higher compared to Pietrain
and the situation was reversed during the first wave of
myogenesis at 21–49 dpc, when the expression was about
1.5 to 2.5-fold higher in Pietrain embryos/fetuses. The
expression profile was very similar to that of SPP1, i.e. it
peaked at 35 dpc and 77 dpc respectively.
Taken together, qPCR confirmed the differential display
RT-PCR derived expression patterns for all three genes
showing stage-associated differential expression and three
out of ten genes with breed-associated differential expres-
sion (overall incidence of false positives ~50%). Further-
more, five of the seven breed-associated genes, whose
differential display expression pattern could not be
reflected in detail by qPCR, showed more than twofold
differences in expression between breeds on at least one
stage.
Discussion
Identification of genes/networks expressed during skeletal 
muscle development in pigs
Myogenesis in mammals is a multistep process that
involves commitment of pluripotent mesodermal cells in
somites to the myogenic lineage, followed by prolifera-
tion/migration of myoblasts and two waves of myoblast
fusion resulting in the formation of two morphologically/
functionally distinct types of myotubes.
In the present study we performed expression profiling of
skeletal muscle development in the pig using embryonic
and fetal musculus longissimus dorsi tissue at seven stages
covering the whole myogenesis from somitogenesis to
maturation of the myotubes into myofibers. Recently Te
Pas et al [11,13] reported results of a similar study analyz-
ing the same breeds and developmental stages using an
application specific microarray focused on genes related
to myogenic regulatory factors, energy metabolism and
structural genes. Here we provide complementary data
generated using differential display RT-PCR as a hypothe-
sis free, open system. We identified 85 transcripts
expressed at one or more of these key stages, evidencing
their potential involvement in myogenesis. These tran-
scripts represented 52 genes from various functional
classes and 33 anonymous EST. Several of them were
either not yet cloned in the pig (~30%), or are completely
novel (~20%). The identified genes and networks and
their relationship with myogenesis are discussed below.
At early developmental stages (14 and 21 dpc) it was not
feasible to dissect structures giving rise to muscle and so
expression profiles of some of the transcripts may have
been influenced by the heterogeneous and changing cellu-
lar composition. For ~50% of the transcripts the expres-
sion profiles derived by differential display RT-PCR and
qPCR are not fully compatible. In the case of stage-associ-
ated EST/genes the consistency of expression patterns in
both breeds provides biological replication and thus
underscores the reproducibility of the results. On the
other hand, the differences in differential display RT-PCR
and qPCR profiles of breed-associated EST/genes, espe-
cially of those displayed in binary fashion, may have
resulted from different sensitivity of the two methods (e.g.
for bR22B1/PDGFRA gene) and polymorphisms in some
of the EST (e.g. bR10D1 and qR10D1). Because for qPCR
very short amplicons are usually designed to achieve high
amplification efficiency it is also possible that in some
cases the differential display cDNA fragment and the
qPCR amplicon represented different splice forms of the
same gene and thus show different profiles.
The differential display patterns revealed on average some
5 bands representing either genes with stage- and/or
breed-specific expression that were further assigned to
groups according to their temporal expression pattern and
to categories of biological functions. A subset of genes rep-
resenting these categories was analysed further by qPCR.
These are discussed in the following paragraphs.BMC Developmental Biology 2007, 7:109 http://www.biomedcentral.com/1471-213X/7/109
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Genes involved in the regulation of transcription
Members of the myogenic regulatory factor (MRF) and
myocyte enhancer factor 2 (MEF2) families of transcrip-
tion factors play a central role in the regulation of myo-
genic determination and differentiation; however, their
expression during porcine myogenesis changes only mar-
ginally [13]. Recently Blais et al [21] identified an exten-
sive network of genes regulating transcription and
chromatin architecture that propagate and amplify the
myogenic signal initiated by the MRFs in vitro. Among the
genes we identified, those regulating transcription repre-
sented one of the most abundantly detected functional
classes, underscoring the important role of transcriptional
regulation in the control of myogenesis. For the majority
of genes identified, their precise role in this process is
largely unknown, but because they were expressed in var-
ious 'period' groups they probably have diverse functions.
The architectural transcription factor HMGA2, for exam-
ple, was recently shown to promote myogenic differentia-
tion in vitro [22]. However, the EST bS3D7 does not show
homology to known cDNA sequence of HMGA2 but to a
sequence segment in the intron 3 of the human HMGA2
[GenBank:AY387666], that was shown to be transcribed
in uterine leiomas. Thus, EST bS3D7 probably represents
a novel exon of porcine HMGA2. Several studies in
humans point to the existence of alternative exons in
intron 3 of HMGA2 with a complex splicing pattern [23].
The porcine EST harbours sequence features that support
the hypothesis of an alternative exon – an open reading
frame (ORF) with a stop codon, a polyadenylation signal
and a poly-A tail. Expression of this exon would generate
a HMGA2 protein with a truncated C-terminal region and
lacking the acidic tail. Intriguingly, overexpression of a
carboxyl-terminally truncated HMGA2 form in embry-
onic stem (ES) cells resulted in enhanced myogenic differ-
entiation compared to wild type HMGA2 cells [22]. Thus
the putative novel exon of porcine HMGA2 may play a
specific function in myogenesis.
Another gene of this functional class, RAB6IP2, showed
consistent upregulation at all seven stages in Pietrain com-
pared to Duroc samples. The function of RAB6IP2  is
poorly understood. Recently, Sigala et al [24] proposed
RAB6IP2 as a part of the IkappaB kinase complex,
involved in activation of the transcription factor NF-kap-
paB. NF-kappaB in turn inhibits myogenic differentiation
and stimulates proliferation of myoblasts by activation of
cyclin D1 transcription and suppression of MYOD [25].
Hence upregulation of RAB6IP2 may be an indicator for
delayed myogenic differentiation via NF-kappaB in Pie-
train.
Genes involved in the control of cell proliferation
Proliferation of myoblasts is stimulated by a variety of
secreted peptide growth factors including insulin-like
growth factors (IGFs) and platelet derived growth factors
(PDGFs). These usually have reverse effect on myogenic
differentiation with the exception of IGFs that stimulate
both proliferation and differentiation of myoblasts [26].
We found a new and largely uncharacterized member of
the IGF system, IGFBPL1, among genes expressed during
the first wave of myogenesis. The IGF binding proteins
(IGFBP) serve as modulators of the effects of IGFs.
IGFBPL1 shows structural and functional similarity to
IGFBP7 [27], that specifies the proliferative response to
IGFs in myogenesis [28]. Taken together the expression
pattern and similarity to IGFBP7 it implies that IGFBPL1
may also serve as a factor stimulating proliferation and/or
inhibiting differentiation of embryonic myoblasts.
The expression profile of PDGFRA showed distinct differ-
ences between Pietrain and Duroc at early stages of myo-
genesis, with Pietrain showing a more pronounced but
delayed peak. PDGFRA plays a vital role in the early myo-
genesis as evidenced by the PDGFRA null mouse showing
impaired myotome formation [29] and (nearly) complete
absence of muscles of the back [30].
Cell adhesion and extracellular matrix genes
Signals generated by adhesive interactions between myob-
lasts and between myoblasts and the extracellular matrix
represent another essential part of the molecular network
governing myogenic differentiation besides secreted fac-
tors and transcription factors [31,32]. Furthermore, cell
adhesion and extracellular matrix molecules serve a struc-
tural role in myoblast fusion and migration, and provide
physical support for the developing myofibers. Consist-
ently, genes involved in cell adhesion, cell-cell signaling,
and extracellular matrix synthesis and remodeling were
abundantly represented and were enriched in the period 4
group, i.e. they were expressed from 21–35 dpc onward.
Several of these, like IGSF1, were not yet associated with
myogenesis.  IGSF1  encodes a member of the immu-
noglobulin superfamily (IgSF) of cell surface proteins
mediating cell adhesion and recognition. Diverse IgSF
members have been implicated in cell-contact-based reg-
ulation of myogenesis [31]. The increasing expression of
IGSF1  towards later stages suggests that it might be
involved in the second wave of myogenesis.
Expression of SPP1 shows a more regulated profile with
peaks at the two respective myogenic waves and consist-
ent upregulation in Duroc compared to Pietrain, espe-
cially at the early stages. SPP1 is multifunctional
matricellular protein mediating cell-adhesion and cellular
signaling via integrin and CD44 receptors. Several lines of
evidence indicate that SPP1 is involved in myogenesis.
SPP1 is a target of MYOD and MYF5 [33] and was shown
to be expressed in vitro in myoblasts and myotubes, with
higher levels in the later [34]. Moreover SPP1 is downreg-BMC Developmental Biology 2007, 7:109 http://www.biomedcentral.com/1471-213X/7/109
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ulated in the BC3H1 cell line, which is myogenic but do
not terminally differentiate, compared to the myogenic
C2C12 cell line, which differentiate normally [35]. Con-
sidering our in vivo and the in vitro evidences for an asso-
ciation between SPP1  expression and myogenic
differentiation it appears that upregulation of SPP1  in
Duroc may be a sign of accelerated myogenesis in this
breed compared to Pietrain.
Differential gene expression as an indicator of cellular 
reorganization during myogenesis
The abundantly identified myofibrillar, cytoskeletal, and
metabolism genes are indicators of the massive structural
and functional remodeling occurring during the develop-
ment of skeletal muscle at the cellular level, including for
example formation of the contractile apparatus. Another
indicator of the ongoing reorganization of cell and tissue
architecture might be the expression of the autophagy
genes ATG3 and UVRAG that we detected during the first
and second wave of myogenesis, respectively. Autophagy
is a process of bulk degradation of cytoplasmatic compo-
nents that occurs in a wide range of eukaryotic organisms
and in multiple different cell types during nutrient and
growth factor deprivation, cellular and tissue remodeling,
and cell death. The importance of autophagy for normal
development is emphasized by frequent observation of
dysregulation of autophagy in cancer [36]. To our best
knowledge there are no reports describing autophagy and
its exact role during myogenesis.
Novel transcripts
Of the 85 EST generated, 33 (~39%) showed no apprecia-
ble similarity to transcripts of known genes. Remarkably,
these EST were enriched among the breed-associated
cDNA-fragments. This finding may indicate that these EST
represent alternative exons with specific temporo-spatial
expression, whose alternative usage may generate tran-
script diversity and ultimately phenotypic (i.e. breed)
diversity [37]. The expression profiles of several of these
EST suggest involvement of the corresponding genes in
myogenesis or prenatal development in general. One
interesting example is the EST qR15C1, whose expression
is upregulated at 21 and 35 dpc. The EST qR15C1 proba-
bly represents a novel exon of KIF26B since comparative
genome analysis showed similarity to intron 4 of the
human ortholog. Moreover, KIF26B  showed a similar
expression profile as it is preferentially expressed in limb
buds and, most notably, in the precursors of hypaxial
muscles in somites of mouse embryos [38].
Implications for the understanding of the genetic control 
of muscle growth
Genetic and epigenetic factors controlling proliferation,
differentiation and cell death affect the number of myob-
lasts available for myofiber formation and thus are impor-
tant determinants of muscle growth. We identified several
novel genes that may be involved in these processes, e.g.
IGFBPL1, during myogenesis. Particularly interesting are
those genes that show differential expression between the
two breeds differing in muscularity. Taken together, the
breed-associated differences in the expression of RAB6IP2,
PDGFRA  and  SPP1  suggest that myogenesis is delayed
especially during the first wave in Pietrain, the more mus-
cular of the two breeds, allowing the generation of a larger
pool of muscle precursor cells. This finding is in accord-
ance with results of Te Pas et al [11], who found that myo-
genesis genes show lower expression in Pietrain compared
to Duroc at early stages, probably delaying formation of
primary myotubes. The number and size of primary myo-
tubes are intrinsic factors affecting secondary fiber
number. In contrast to secondary myotubes, whose
number is sensitive to exogenous factors, e.g. nutrition,
the number of primary myotubes is genetically pro-
grammed [39]. Thus genetic selection may impinge on the
first wave of myogenesis, promoting genes active at this
stage as primary candidates for manipulation of muscle
growth.
Conclusion
The present study revealed several genes differentially
expressed during skeletal muscle development of domes-
tic pig that were not yet associated with myogenesis and
thus provide novel insights into molecular pathways
employed in mammalian myogenesis (e.g. the autophagy
pathway) and a foundation for future functional studies.
Genes that exhibited differences between the divergent
breeds represent candidate genes for muscle growth and
structure. Indeed several of the identified genes map to
known porcine QTL regions affecting muscle growth and/
or structure and their DNA variation is associated with
variation in traits related to muscle deposition [40,41].
Methods
Tissue sampling and RNA extraction
To obtain embryos/fetuses 99 Pietrain and 105 Duroc
sows respectively (12 to 17 sows per stage) were artificially
inseminated with semen from purebred sires and slaugh-
tered at 14, 21, 35, 49, 63, 77 and 91 days post conception
(dpc). Immediately after exsanguination of the sows the
uteri were recovered and the embryos/fetuses were quickly
removed, weighted (35 dpc onward), and dissected. Sam-
ples were frozen in liquid nitrogen and stored at -80°C.
To harvest the embryos at 14 dpc each uterus horn was
flushed with PBS, i.e. at this stage each sample represented
the whole litter of a sow. At 21 dpc whole embryos were
collected and for RNA isolation the dorsolateral part was
used. At 35 dpc precursor tissue of the back muscles was
dissected from the area along the spine. From day 49 dpc
onward Musculus longissimus dorsi (Mld) tissue samples
were dissected. In total about 1000 samples from each ofBMC Developmental Biology 2007, 7:109 http://www.biomedcentral.com/1471-213X/7/109
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the two breeds were collected. In addition Mld samples
from each three Pietrain and Duroc sows respectively were
obtained. All handling of the animals was done in accord-
ance with German law for the Protection of Animals and
was approved by the animal welfare protection commis-
sion of the University of Bonn and the responsible veteri-
nary authority.
Before 49 dpc the sexual characteristics were not visible
therefore gender of the embryos and fetuses at 21 and 35
dpc was determined using a PCR-based method according
to [42] with minor modifications. Briefly, a fragment of
the sex-determining region Y located on the Y chromo-
some was amplified using the primers SRYB-3 and SRYB-
5 along with the autosomal locus STS-Bo1 [43] serving as
an internal control. The cycling parameters used were as
follows: 95°C for 3 min; 36 cycles of 95°C for 10 s, 62°C
for 30 s, 72°C for 30 s; and 72°C for 5 min.
Total RNA was isolated using TRI Reagent (Sigma,
Taufkirchen, Germany) according to the manufacturer's
protocol. After DNaseI treatment (Promega, Mannheim,
Germany) the RNA was cleaned up using the RNeasy Kit
(Qiagen, Hilden, Germany), the quantity was spectropho-
tometrically determined and the integrity checked by elec-
trophoresis of 500 ng RNA on ethidium bromide stained
1% denaturing agarose gels. In addition absence of DNA
contamination was checked using the RNA as a template
in a PCR amplifying a fragment of the glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) gene.
Differential display RT-PCR
To minimize the negative impact of individual variation
in the gene expression on the expression profiles RNA
pools were used for each stage and breed, i.e. 14 RNA
pools were made (2 breeds × 7 stages). With the exception
of the embryo samples at 14 dpc the pools were prepared
by mixing of equal amounts of RNA from 10 individuals
per breed, one male and one female sibling from 5 litters
per stage. The individuals were selected according to their
age and weight/size to be representative for their breeds at
the chosen developmental stages. For the embryos at 14
dpc the individuals were already pooled during the har-
vesting, therefore the RNA pools were set up from uterus
flushes of 5 sows per breed.
First-strand cDNA was synthesized using SuperScriptII
MMLV reverse transcriptase (Invitrogen, Karlsruhe, Ger-
many) and each of the oligo (dT)11CG, (dT)11GC,
(dT)11GG und (dT)11CC primers. Differential display RT-
PCR was performed according to [19] using random
decamer primers developed by Bauer et al. [44]. In total
88 primer combinations were used to generate differential
display profiles. Each differential display RT-PCR was per-
formed in duplicate to minimize false positives and the
PCR products from both reactions were loaded in parallel
on 5 % denaturing polyacrylamide gels, separated by elec-
trophoresis for 4.5 hours and visualized by silver staining.
Isolation, sequencing and annotation of the differentially 
displayed cDNA fragments
Selected cDNA fragments with breed or stage-associated
appearance were excised using sterile needles, eluted in 2
× PCR buffer at 4°C overnight, precipitated using linear
acrylamide as carrier, eluted in 20 µl of PCR grade H2O,
and reamplified using the same PCR conditions as for dif-
ferential display RT-PCR but with the cycle number
increased to 50. Presence of the target fragment was
checked by running an aliquot of the reamplification on 5
% denaturing PAA gels. The reamplified products were
subsequently purified on 1 % agarose gels and cloned
using either the pGEM-T (Promega) or the pCR2.1 (Invit-
rogen) vector. Following an insert amplification using
M13 primers at least two clones per fragment were
sequenced on Licor 4200 sequencer using the SequiTherm
EXCEL Kit (Biozym, Hess. Oldendorf, Germany) and Sp6
and T7 primers. The identity of the expressed sequence
tags (EST) was first determined by BLASTN search against
the nonredundant and EST GenBank repositories
(BLASTN identities > 80%). For EST for which sequence
identity was found only to anonymous EST or genomic
clones the corresponding gene was attempted to be iden-
tified by cross-species megaBLAST search against the
human genome by taking advantage of the high homol-
ogy between pig and human genome sequences. The EST
for which the gene identity could be derived were assigned
to functional categories based on GO annotation where
available or inferred from the available literature.
Real-time quantitative PCR
Real-time quantitative PCR (qPCR) was employed for val-
idation of the expression patterns of selected EST.
Primers and amplicons shown in Table 3, were designed
using the Primer Express v2.0 (Applied Biosystems, Weit-
erstadt, Germany). For all target EST/genes with the excep-
tion of the SPP1 gene, the LXN gene and the EST qR15C1
the primers were designed from sequences obtained in the
present study. The sequences of the EST qR14A1#1 (LXN)
and qR15C1 were too short to design primers suitable for
qPCR therefore overlapping sequences, identified by
BLASTN search of available porcine sequences, were used
for primer/amplicon design (Table 3). For the SPP1 gene
the porcine reference sequence was used (Table 3).
Sequences of the ACTB, CANX, AGPAT1 and RPL32 genes
were retrieved from GenBank by BLASTN search using the
corresponding human gene as reference. The primers used
for quantification of the POLR2A gene were kindly pro-
vided by Dr. Manfred Mielenz, Institute of Physiology,
Biochemistry and Animal Hygiene, University of Bonn.BMC Developmental Biology 2007, 7:109 http://www.biomedcentral.com/1471-213X/7/109
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Template first strand cDNA for validation was synthesized
from the original 14 RNA pools used for the differential
display RT-PCR using SuperScriptIII MMLV reverse tran-
scriptase (Invitrogen) in a reaction containing 1 µg RNA
and oligo (dT)11VN primer according to the manufac-
turer's protocol. In addition cDNA was synthesized using
RNA pools from Mld tissue of 3 adult sows per breed as
template.
Absolute quantification of the expression was performed
on an ABI Prism 7000 SDS Instrument SDS v1.1 using the
SYBR Green JumpStart Taq ReadyMix (Sigma) or, for the
GATA3 and the RPL32 genes, on a LightCycler 1.0 System
using the LightCycler FastStart DNA Master SYBRplus
Green I (Roche Diagnostics, Mannheim, Germany). All
reactions were performed in duplicate with standard devi-
ation between replicates kept below fifty percent. On the
ABI Prism 7000 SDS Instrument a two-step PCR was per-
formed with an initial denaturation at 95°C for 10 min
and 45 cycles of 95°C for 15 s for denaturation and one-
minute annealing/extension at optimized temperature
(Ta, Table 3). The fluorescence was acquisited at the end
of each cycle at a fixed temperature of 60°C. On the Light-
Cycler instrument the qPCR consisted of an initial dena-
turation step at 95°C for 10 min and 45 cycles consisting
of 95°C for 10s, optimal Ta for 15 s and extension at 72°C
for 15 s. The fluorescence was acquisited at the end of the
extension step. After completion of the qPCR on both
instruments melting curve analysis and afterwards agarose
gel electrophoresis were performed to confirm specificity
of the amplification.
Table 3: Information on primers used for qPCR
Gene/EST Source Primer Sequence Ta (°C) Amplicon size (bp)
ACTB1 AJ312193 GAGAAGCTCTGCTACGTCGC 59 231
CCTGATGTCCACGTCGCACT
POLR2A1 DT324622 GAAGGGGGAGAGACAAACTG 60 86
GGGAGGAAGAAGAAAAAGGG
RPL321 NM_001001636 AGCCCAAGATCGTCAAAAAG 55 165
TGTTGCTCCCATAACCAATG
AGPAT11 AL773562 AGGACGCAACGTCGAGAACA 60 110
GTGAGGGAGGGAAGTGGTGAG
CANX1 AJ653783 CAATGATGGATGGGGTCTGAA 60 135
AACACAGGTAATGCCACAGTCAA
NME12 EH792596 TGTGGAGAGCGCAGAGAAAGA 58 143
GGGAGAGAGGAGAAATGGAATGG
IGSF12 EH792632 GAGTCCACCCCATCTACTGTTCC 60 60
AAATCCCCTTGACCCATCTCA
HMGA22 EH792601 AAGGAGGCAGAAGCAGAATGA 59 74
TGGAGACCCTCAGAGACAAGAA
GATA33 EH792592 CTTAGGGAAGATGAGTCTGAATGG 59 125
TTTTGAAGGCAGAAAGCGAAG
SPP13 X16575 TTGCTAAAGCCTGACCCATCT 60 145
CGTCGTCCACATCGTCTGTT
SMC6L13 EH792668 TGAGGCAGTATCAAGAAGCAAAAG 58 189
AACAACAGCAACAAAAGAGCCAA
RAB6IP23 EH792612 GGATGTGAAGGAGCGGAAAG 60 121
AGCCTGCAATGATTTGACTCG
PDGFRA3 EH792663 CAGGCAGGTTGGAGGGAGAT 60 101
AAGTTGCGGAGGTTGGATTCT
TJP13 EH792652 CTGGGCTCTTGGCTTGCTATTC 60 130
CTCCTCCTGCCGTTTTTGG
LXN3 CB477731 CAAGCAAGTGCAAAGAAATGATG 60 151
TGGCAGACGGCTGTTATGTT
NRAP3 EH792618 AAGTGAGGCAGTCTCCAGAGG 60 86
CATATCCCAGTGAAACACCGAT
qR15C13 Ti784825315 ACAGTGAGAGCGAGCGTGATG 60 158
TGCTTTCCCTTTATCGGAGG
bR10D13 DQ631863 GCTACACATTCAGCACAGAGTAAGA 60 126
CTGGGGAAAGACTCCAAAAGA
1Reference gene
2Gene showing stage-associated differential expression as revealed by differential display RT-PCR
3Gene showing breed-associated differential expression as revealed by differential display RT-PCRBMC Developmental Biology 2007, 7:109 http://www.biomedcentral.com/1471-213X/7/109
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For all assays threshold cycles were converted to copy
numbers using a standard curve generated by amplifying
serial dilutions of an external plasmid standard (107 - 101
copies). To account for variation in RNA input and effi-
ciency of reverse transcription the calculated copy num-
bers were normalized by dividing with a normalization
factor derived from the expression of the five (three for
adult stage) reference genes. First, for each reference gene
a correction factor was calculated within stage and breed
by dividing the quantity obtained for the corresponding
breed by the mean quantity of the two breeds at that spe-
cific stage. The normalizing factor was then calculated for
each breed and stage based on the geometric mean of the
five (three) correction factors.
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